
23 Feb Caribou Biosciences
Denis Sirringhaus, Executive Director of Business Development
Oct. 10 | 1:30pm | Ecolab Life Sciences Ballroom
Berkeley, CA
(NASDAQ: CRBU)
Clinical-stage biopharmaceutical company focused on developing transformative genome-edited allogeneic cell therapies for devastating human diseases.